Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

Extreme Language Ultra-High Potency
The newest generation of small-molecule therapies bring containment needs well beyond those of conventional HPAPIs. What does this mean for the pharma lexicon – and the pharma landscape? read more
AI in Pharmacovigilance: Key Takeaways from Boehringer Ingelheim’s Recent Rollout
In conversation with Pharmaceutical Outsourcing, Claudia Lehman, Head of Global Pharmacovigilance Operations at Boehringer Ingelheim and Lucinda Smith, ArisGlobal’s Chief Safety Product Officer, reflect on some of the lessons learned from Boehringer’s deployment of AI to date in targeted use cases, starting with adverse event case intake and processing. read more
Engaging with Regulators for Single-Arm Oncology Research Trials
When well-planned and well-executed, single-arm trials can accelerate access to life-saving therapies that might otherwise never reach desperate cancer patients. read more
Executive Q&A - Early Drug Development
In this Q&A, we explore early-stage pharmaceutical drug development trends, key scientific and technical challenges, and the role emerging technologies play in enhancing efficiency and quality during early pharmaceutical development. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Agilent and Veeda Lifesciences Collaborate to Accelerate GLP-1 and Complex Biologics Development Services
Thursday, May 14, 2026
Agilent Technologies announced a strategic collaboration with Veeda Lifesciences to strengthen regulatory-aligned analytical and bioanalytical ... read more
Piramal Pharma Solutions Opens Payload-Linker Suite at its Riverview, Michigan Facility
Wednesday, May 13, 2026
This launch is a key element of the company's broader $90 million investment plan to extend U.S.-based manufacturing capabilities, announced last year read more
OrganaBio Acquires Excellos Operating Assets
Wednesday, May 13, 2026
OrganaBio has acquired substantially all of the operating assets of San Diego-based Excellos Inc. to create a bicoastal cell therapy contract ... read more
Vetter Starts Construction of a New Production Site in Germany
Wednesday, May 13, 2026
Vetter announced the start of construction on its new site in Saarlouis. During the first construction phase, the company will build a state-of-the-... read more
Avid Bioservices Appoints Chief Commercial Officer
Tuesday, May 12, 2026
Avid Bioservices announced the appointment of Kerri McCullough Wood as Chief Commercial Officer. read more